LIN ELIZABETH YEU sold 89.8% of their position (13.95K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.22M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/9/2026ACC: 0001842190-26-000011
Director
Since Dec 2021
-13.95K
Net shares
Net seller
$1.22M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
13.95K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−5.39K
Price / share
$85.00
Trade value
$457.89K
% of position
40.4%
9/4/2026
13.32K→7.93K
Common Stock
Direct
Shares
−5.39K
Price / share
$90.00
Trade value
$484.74K
% of position
67.9%
9/4/2026
7.93K→2.55K
Common Stock
Indirect
Shares
−1.59K
Price / share
$85.00
Trade value
$135.15K
% of position
33.3%
9/4/2026
4.77K→3.18K
Common Stock
Indirect
Shares
−1.59K
Price / share
$90.00
Trade value
$143.10K
% of position
50.0%
9/4/2026
3.18K→1.59K
Total
Net shares
−13.95K
Net value
-$1.22M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/4/2026 | S · Sale | −5.39K | $85.00 | $457.89K | 40.4% | 13.32K | 7.93K |
| Common Stock Direct | 9/4/2026 | S · Sale | −5.39K | $90.00 | $484.74K | 67.9% | 7.93K | 2.55K |
| Common Stock Indirect | 9/4/2026 | S · Sale | −1.59K | $85.00 | $135.15K | 33.3% | 4.77K | 3.18K |
| Common Stock Indirect | 9/4/2026 | S · Sale | −1.59K | $90.00 | $143.10K | 50.0% | 3.18K | 1.59K |
| Total | −13.95K | -$1.22M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned12.04K
Total
12.04K indirect12.04K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 12.04K | Indirect |
| Total | 12.04K | 12.04K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported